158 related articles for article (PubMed ID: 24330255)
21. Occupational exposure to the sun and risk of skin and lip cancer among male wage earners in Denmark: a population-based case-control study.
Kenborg L; Jørgensen AD; Budtz-Jørgensen E; Knudsen LE; Hansen J
Cancer Causes Control; 2010 Aug; 21(8):1347-55. PubMed ID: 20383781
[TBL] [Abstract][Full Text] [Related]
22. A review of heart transplant immunosuppressants and nonmelanoma skin cancer.
Eckembrecher DG; Eckembrecher FJ; Camacho I; Shah H; Dave Y; Patel S; Nouri K
Arch Dermatol Res; 2023 Nov; 315(9):2491-2503. PubMed ID: 37256379
[TBL] [Abstract][Full Text] [Related]
23. Prolonged risk of specific malignancies following cyclophosphamide therapy among patients with granulomatosis with polyangiitis.
Faurschou M; Mellemkjaer L; Voss A; Keller KK; Hansen IT; Baslund B
Rheumatology (Oxford); 2015 Aug; 54(8):1345-50. PubMed ID: 25234661
[TBL] [Abstract][Full Text] [Related]
24. Myasthenia gravis in children: a longitudinal study.
Ashraf VV; Taly AB; Veerendrakumar M; Rao S
Acta Neurol Scand; 2006 Aug; 114(2):119-23. PubMed ID: 16867035
[TBL] [Abstract][Full Text] [Related]
25. In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis.
Wang LE; Xiong P; Strom SS; Goldberg LH; Lee JE; Ross MI; Mansfield PF; Gershenwald JE; Prieto VG; Cormier JN; Duvic M; Clayman GL; Weber RS; Lippman SM; Amos CI; Spitz MR; Wei Q
J Natl Cancer Inst; 2005 Dec; 97(24):1822-31. PubMed ID: 16368944
[TBL] [Abstract][Full Text] [Related]
26. Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study.
Tessari G; Naldi L; Boschiero L; Nacchia F; Fior F; Forni A; Rugiu C; Faggian G; Sassi F; Gotti E; Fiocchi R; Talamini G; Girolomoni G
Arch Dermatol; 2010 Mar; 146(3):294-9. PubMed ID: 20231501
[TBL] [Abstract][Full Text] [Related]
27. Hydrochlorothiazide use and risk for Merkel cell carcinoma and malignant adnexal skin tumors: A nationwide case-control study.
Pedersen SA; Johannesdottir Schmidt SA; Hölmich LR; Friis S; Pottegård A; Gaist D
J Am Acad Dermatol; 2019 Feb; 80(2):460-465.e9. PubMed ID: 29913261
[TBL] [Abstract][Full Text] [Related]
28. Safety of long-term combined immunosuppressive treatment in myasthenia gravis--analysis of adverse effects of 163 patients.
Rozsa C; Lovas G; Fornadi L; Szabo G; Komoly S
Eur J Neurol; 2006 Sep; 13(9):947-52. PubMed ID: 16930359
[TBL] [Abstract][Full Text] [Related]
29. [Myasthenia gravis. Opportunistic cytomegalovirus infection after long-term azathioprine therapy].
Eisensehr I; Büttner U; Witt TN; von Appen K; Spuler S
Nervenarzt; 1999 Oct; 70(10):924-6. PubMed ID: 10554786
[TBL] [Abstract][Full Text] [Related]
30. Chronic diseases requiring hospitalization and risk of non-melanoma skin cancers--a population based study from Denmark.
Jensen AØ; Olesen AB; Dethlefsen C; Sørensen HT; Karagas MR
J Invest Dermatol; 2008 Apr; 128(4):926-31. PubMed ID: 17914446
[TBL] [Abstract][Full Text] [Related]
31. Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study.
Confavreux C; Saddier P; Grimaud J; Moreau T; Adeleine P; Aimard G
Neurology; 1996 Jun; 46(6):1607-12. PubMed ID: 8649558
[TBL] [Abstract][Full Text] [Related]
32. Risk of nonmelanoma skin cancer with azathioprine use.
Maddox JS; Soltani K
Inflamm Bowel Dis; 2008 Oct; 14(10):1425-31. PubMed ID: 18383175
[TBL] [Abstract][Full Text] [Related]
33. Flecainide and risk of skin neoplasms: Results of a large nested case-control study in Spain and Denmark.
Reyes C; León-Muñoz LM; Pistillo A; Jóhannesdóttir Schmidt SA; Kristensen KB; Puente D; LLorente-García A; Huerta-Álvarez C; Pottegård A; Duarte-Salles T
Front Pharmacol; 2022; 13():1002451. PubMed ID: 36618916
[No Abstract] [Full Text] [Related]
34. Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma.
Ingvar A; Smedby KE; Lindelöf B; Fernberg P; Bellocco R; Tufveson G; Höglund P; Adami J
Nephrol Dial Transplant; 2010 Aug; 25(8):2764-71. PubMed ID: 19729465
[TBL] [Abstract][Full Text] [Related]
35. Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: follow-up data from European Vasculitis Study Group clinical trials.
Heijl C; Harper L; Flossmann O; Stücker I; Scott DG; Watts RA; Höglund P; Westman K; Mahr A;
Ann Rheum Dis; 2011 Aug; 70(8):1415-21. PubMed ID: 21616914
[TBL] [Abstract][Full Text] [Related]
36. Azathioprine as a single immunosuppressive drug in the treatment of myasthenia gravis.
Cosi V; Lombardi M; Erbetta A; Piccolo G
Acta Neurol (Napoli); 1993 Apr; 15(2):123-31. PubMed ID: 8328322
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for non-melanoma skin cancer in kidney transplant patients in a Spanish population in the Mediterranean region.
Bernat García J; Morales Suárez-Varela M; Vilata JJ; Marquina A; Pallardó L; Crespo J
Acta Derm Venereol; 2013 Jul; 93(4):422-7. PubMed ID: 23303600
[TBL] [Abstract][Full Text] [Related]
38. Azathioprine toxicity during long-term immunosuppression of generalized myasthenia gravis.
Hohlfeld R; Michels M; Heininger K; Besinger U; Toyka KV
Neurology; 1988 Feb; 38(2):258-61. PubMed ID: 3340289
[TBL] [Abstract][Full Text] [Related]
39. First and subsequent nonmelanoma skin cancers: incidence and predictors in a population of New Zealand renal transplant recipients.
Mackenzie KA; Wells JE; Lynn KL; Simcock JW; Robinson BA; Roake JA; Currie MJ
Nephrol Dial Transplant; 2010 Jan; 25(1):300-6. PubMed ID: 19783601
[TBL] [Abstract][Full Text] [Related]
40. [Hypersensitivity to azathioprine can simulate an aggravation of myasthenia].
Chevrel G; Moreau T; Vial T; Payen C; Confavreux C
Therapie; 1998; 53(1):77-8. PubMed ID: 9773103
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
